1. The Chemotherapy Program of the National Cancer Institute: history analysis and plans;Zubrod;Cancer Chemother. Rep,1966
2. Quantitative concepts in the clinical study of drugs;Zubrod,1964
3. Implications of biochemical, cytokinetic, pharmacologic and toxicologic relationships in the design of optimal therapeutic schedules;Skipper;Cancer Chemother. Rep,1970
4. a commentary: Treatment schedule dependency of experimentally active antileukemic (L1210) drugs;Venditti;Cancer Chemother. Rep,1971
5. Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-β-D-arabinofuranosyl cytosine and the 5'-triphosphate of 9-β-D-arabinofuranosyladenine;Furth;Cancer Res,1968